Article info
PDFWhat to do when
A practical guide to the treatment of neuromyelitis optica
- Correspondence to Dr Jackie Palace, Department of Clinical Neurology, John Radcliffe Hospital, Oxford OX3 9DU, UK; jacqueline.palace{at}ndcn.ox.ac.uk
Citation
A practical guide to the treatment of neuromyelitis optica
Publication history
- Received January 25, 2012
- Accepted June 10, 2012
- First published August 6, 2012.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- Neuromyelitis optica spectrum disorder (NMOSD) presenting as acute transverse myelitis with positive aquaporin 4 antibodies
- Overlapping CNS inflammatory diseases: differentiating features of NMO and MS
- Relapsing neuromyelitis optica in an adolescent girl
- A practical approach to the diagnosis of spinal cord lesions
- Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features
- The borderland of neuromyelitis optica
- Neurodegeneration in multiple sclerosis and neuromyelitis optica